INTELLECTUAL PROPERTY: WHO-WIPO-WTO BOOK
Promoting Access to Medical Technologies and Innovation:
Intersections between public health, intellectual property and trade
Abbreviations
ACTA |
Anti-Counterfeiting Trade Agreement |
AFRO |
WHO Regional Office for Africa |
AMC |
Advance Market Commitment |
AMF |
Access to Medicine Foundation |
AMRH |
African Medicines Regulatory Harmonization |
ANDI |
African Network for Drugs and Diagnostics Innovation in Africa |
API |
active pharmaceutical ingredient |
ARIPO |
African Regional Intellectual Property Organization |
ARV |
antiretroviral |
ASAQ |
artesunate and amodiaquine |
ASEAN |
Association of Southeast Asian Nations |
ATC |
Anatomical Therapeutic Chemical |
BTA |
bilateral trade agreement |
BVGH |
BIO Ventures for Global Health |
CAFTA-DR |
Dominican Republic–Central America–United States Free Trade Agreement |
CAM |
complementary and alternative medicine |
CAMR |
Canada’s Access to Medicines Regime |
CAN |
Andean Community |
CARIFORUM |
Caribbean Forum of African, Caribbean and Pacific States |
CBD |
Convention on Biological Diversity |
CDIP |
Committee on Development and Intellectual Property |
CEWG |
Consultative Expert Working Group on Research and Development: Financing and Coordination |
CESCR |
Committee on Economic, Social and Cultural Rights |
CHAI |
Clinton Health Access Initiative |
CIOMS |
Council for International Organizations of Medical Sciences |
CIPIH |
Commission on Intellectual Property Rights, Innovation and Public Health |
CMH |
Commission on Macroeconomics and Health |
COHRED |
Council on Health Research for Development |
COPD |
chronic obstructive pulmonary disease |
CSIR |
Council of Scientific and Industrial Research |
CTD |
Common Technical Document |
DALY |
disability-adjusted life year |
DMEPA |
Division of Medication Error Prevention and Analysis |
DNDi |
Drugs for Neglected Diseases initiative |
Doha Declaration |
Declaration on the TRIPS Agreement and Public Health |
EAC |
East African Community |
EBS |
equitable benefit-sharing |
EDCTP |
European and Developing Country Clinical Trials Partnership |
EFTA |
European Free Trade Association |
EMA |
European Medicines Agency |
EMRO |
WHO Regional Office for the Eastern Mediterranean |
EML |
Model List of Essential Medicines |
EPC |
European Patent Convention |
EPO |
European Patent Office |
EWG |
Expert Working Group on Research and Development: Financing and Coordination |
FDA |
US Food and Drug Administration |
FDI |
foreign direct investment |
FTA |
free trade agreement |
FTC |
US Federal Trade Commission |
FTO |
freedom to operate |
GACP |
good agricultural and collection practices |
GATS |
General Agreement on Trade in Services |
GATT |
General Agreement on Tariffs and Trade |
GBD |
global burden of disease |
GCC |
Gulf Cooperation Council |
GDP |
gross domestic product |
GHTF |
Global Harmonization Task Force |
GISRS |
Global Influenza Surveillance and Response System |
Global Fund |
Global Fund to Fight AIDS, Tuberculosis and Malaria |
GMP |
good manufacturing practice |
GPA |
Agreement on Government Procurement |
GPO |
Government Pharmaceutical Organization |
GPP/GCC |
Group Purchasing Program of Gulf Cooperation Council |
GR |
genetic resources |
GSPA-PHI |
WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property |
HAI |
Health Action International |
Hib |
Haemophilus influenzae type b |
HRC |
Human Rights Council |
HS |
Harmonized Commodity Description and Coding System |
IAVI |
International AIDS Vaccine Initiative |
ICDRA |
International Conference of Drug Regulatory Authorities |
ICESCR |
International Covenant on Economic, Social and Cultural Rights |
ICH |
International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use |
ICT |
information and communications technology |
ICTRP |
International Clinical Trials Registry Platform |
ICTSD |
International Centre for Trade and Sustainable Development |
IFPMA |
International Federation of Pharmaceutical Manufacturers & Associations |
IGC |
Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC) |
IGPA |
International Generic Pharmaceutical Alliance |
IGWG |
Intergovernmental Working Group on Public Health, Innovation and Intellectual Property |
IMDRF |
International Medical Device Regulators Forum |
IMPACT |
International Medical Products Anti-Counterfeiting Taskforce |
InChl |
International Chemical Identifier |
INN |
international nonproprietary name |
IP |
intellectual property |
IPC |
International Patent Classification |
IPRs |
intellectual property right |
IRCH |
International Regulatory Cooperation for Herbal Medicines |
IRP |
international reference price |
IUPAC |
International Union of Pure and Applied Chemistry |
KEI |
Knowledge Ecology International |
LDC |
least-developed country |
LMIC |
low- and middle-income country |
Madrid System |
Madrid System for the International Registration of Marks |
MATH |
Medicines, Access, Trade & Health |
MDG |
Millennium Development Goal |
MPP |
Medicines Patents Pool |
MPR |
median price ratio |
MERCOSUR |
Southern Common Market |
MFN |
most favoured nation |
MIWI |
"Made in the World" initiative |
MMV |
Medicines for Malaria Venture |
MSF |
Médecins Sans Frontières |
Nagoya Protocol |
Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity |
NCD |
non-communicable disease |
NCE |
new chemical entity |
NCI |
National Cancer Institute |
NEPAD |
New Partnership for African Development |
NGO |
non-governmental organization |
NIC |
National Influenza Centre |
NICHSR |
National Information Center on Health Services Research and Health Care Technology |
NIH |
National Institutes of Health |
NME |
new molecular entity |
NRG |
(Invented) Name Review Group |
NTD |
neglected tropical disease |
NTM |
non-tariff measure |
OECD |
Organisation for Economic Co-operation and Development |
OECS |
Organisation of Eastern Caribbean States |
OHCHR |
Office of the United Nations High Commissioner for Human Rights |
OSDD |
Open Source Drug Discovery |
OWEG |
Open-Ended Working Group of Member States on Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccines and other Benefits |
PAHO |
Pan American Health Organization |
PANDRH |
Pan American Network for Drug Regulatory Harmonization |
Paris Convention |
Paris Convention for the Protection of Industrial Property |
PARLATINO |
Latin American Parliament |
PATH |
Programme for Appropriate Technology in Health |
PBM |
pharmacy benefit management |
PCT |
Patent Cooperation Treaty |
PCV |
pneumococcal conjugate vaccine |
PDP |
product development partnership |
PEPFAR |
President’s Emergency Plan for AIDS Relief |
PhRMA |
Pharmaceutical Research and Manufacturers of America |
PIC |
prior informed consent |
PIP Framework |
Pandemic Influenza Preparedness Framework for the Sharing of Influenza Viruses and Access to Vaccines and other Benefits |
PLoSNTD |
Public Library of Science-Neglected Tropical Diseases |
PPP |
public–private partnership |
PQR |
Price and Quality Reporting |
PRV |
priority review voucher |
PTA |
preferential trade agreement |
R&D |
research and development |
RTA |
regional trade agreement |
SARS |
severe acute respiratory syndrome |
SCP |
Standing Committee on the Law of Patents |
SCT |
Standing Committee on the Law of Trademarks, Industrial Designs and Geographical Indications |
SDR |
Special Drawing Right |
SFFC |
spurious/falsely-labelled/falsified/counterfeit |
SMTA |
Standard Material Transfer Agreement |
SPC |
supplementary protection certificate |
SPS |
sanitary and phytosanitary |
SPS Agreement |
Agreement on the Application of Sanitary and Phytosanitary Measures |
TB |
tuberculosis |
TBT |
technical barriers to trade |
TBT Agreement |
Agreement on Technical Barriers to Trade |
TBT Committee |
Committee on Technical Barriers to Trade |
TCM |
Traditional Chinese Medicine |
TDR |
WHO Special Programme for Research and Training in Tropical Diseases |
TK |
traditional knowledge |
TKDL |
Traditional Knowledge Digital Library |
TRIPS |
trade-related aspects of intellectual property rights |
TRIPS Agreement |
Agreement on Trade-Related Aspects of Intellectual Property Rights |
TWN |
Third World Network |
UNAIDS |
Joint United Nations Programme on HIV/AIDS |
UNCTAD |
United Nations Conference on Trade and Development |
UNDP |
United Nations Development Programme |
UNECA |
United Nations Economic Commission for Africa |
UNFPA |
United Nations Population Fund |
UNICEF |
United Nations Children's Fund |
USPTO |
United States Patent and Trademark Office |
VAT |
value added tax |
WASH |
Water, Sanitation and Hygiene for All |
WHA |
World Health Assembly |
WHO |
World Health Organization |
WIPO |
World Intellectual Property Organization |
WMA |
World Medical Association |
WTO |
World Trade Organization |
YLD |
years lost due to disability |
YLL |
years of life lost |
The word “country” is sometimes used to describe what are officially “customs territories”, and not necessarily countries in the usual sense of the word.